Description
This research blend combines BPC-157, a synthetic 15-residue peptide, with TB-500, a peptide related to the actin-binding region of thymosin beta-4. The two are among the most frequently studied peptides in the preclinical tissue-repair literature, and investigators often examine them side by side.
BPC-157 has been studied for its influence on angiogenesis and fibroblast migration in rodent tendon, muscle and gut models, whereas thymosin beta-4 fragments have been investigated for actin regulation, cell motility and extracellular-matrix remodelling. A combined vial simplifies experiments designed to compare single-peptide and paired conditions. The labelled strength is the total peptide per vial, split equally: the 10 mg kit contains 5 mg of each peptide and the 20 mg kit 10 mg of each.
Store the lyophilised blend sealed and cold, protected from light.
Research chemical only. The summary above reflects published preclinical literature and is not a statement of suitability for any human or veterinary use.
Supplied as a 10-vial kit of lyophilised powder. Dispatched in 1–2 business days.




